10x Genomics, Inc. is trading at $32.52 (+2.43%) today, extending a strong rally that began on June 15, driven by the announcement of a multi-year research collaboration with Cleveland Clinic. The partnership aims to advance research in novel diagnostics for bladder cancer using 10x's Flex Apex and Xenium platforms. This news follows the stock's previous session's surge of 11.72% from $28.84 to $32.22.